t The estradiol benzoate (Progynon B) was supplied by Dr. E. Schwenk of the Schering Corporation. The equilin, equilin benzoate, and equilenin benzoate were supplied by Dr. A. Girard, Paris. The estradiol dipropionate was supplied by Dr. E. Oppenheimer of the Ciba Pharmaceutical Laboratories. The stilbestrol was supplied by J. A. Morrell of E. R. Squibb & Sons. The testosterone propionate (Oreton) was supplied by Drs. E. Schwenk and M. Gilbert of the Schering Corporation. The writers wish to express their appreciation for the generous assistance of the above commercial and research laboratories in facilitating these investigations. estrogens were dissolved in sesame oil and injected subcutaneously. In addition, other mice were given estrogens and testosterone propionate simultaneously. The pituitary glands were removed from the opened skulls either before or after fixation in 10 per cent formalin, and when in 80 per cent alcohol weighed on a torsion balance sensitive to 0.5 mg. After many observations had been made only those glands showing evidence of grossly apparent hypertrophy were weighed. The tissues were sectioned at 5 micra and stained with hematoxylin-eosin or iron hematoxylin-Mallory triple connective-tissue stain (Crooke's modification).2
Observations
The pituitary glands of mice of all the strains studied increased in size and showed a degranulation of the basophilic cells following the injection of estrogens. The glands of the mice of 6 strains which received estrogens (A, C3H, CBA, C12I, N, and JK) usually weighed from 2 to 3 mg. and seldom weighed more than 4 mg. (from 1.5 to 3 times the weight of glands of untreated mice). Rarely were glands found that weighed 6 mg. In one mouse from the C3H strain the pituitary body weighed 8.5 mg. The slightly or more extensively enlarged glands of these strains were always uniform in shape and regular in outline. Many of the mice of these strains received estrogens for more than 300 days. In the C12I, N, and JK strains few animals tolerated treatment for longer periods. The predominant structural changes were a slight enlargement of the vascular sinuses, an increase in the non-granular cells, and a marked decrease in granular basophilic cells.
Fourteen were most pronounced at the periphery of the gland where very few or no eosinophilic cells were present over considerable areas. The central areas near the pars intermedia showed a more normal distribution of the eosinophilic cells. Very few or no granular basophilic cells were present even in this area. Particularly in the lateral lobes of the glands distended vascular sinuses widely separated the cell cords. In all of these hypophyses the changes were of a general hyperplastic nature. The hypophyses weighing from 47 to 87 mg. presented a different histological picture. The greater portion of the glands consisted of densely placed cords of uniformly enlarged chromophobic cells and occasional hemorrhagic areas. The chromophobic cells showed a characteristic radial arrangement around the larger vessels. Mitotic figures were frequently found. Relatively clear areas larger than the nuclei were present in the cytoplasm of the tumor cells (Fig. 4) . These areas were considered as possible negative Golgi images. A few eosinophilic cells were observed near the pars ner-vosa of the one hypophysis weighing 47 mg., though the greater part of the gland was composed of dense hyperplastic tissue. Areas of gland of normal structure were not found in the large tumors. Evidence of invasion of the surrounding tissues was lacking. Pieces of one tumor (Fig. 3) were grafted subcutaneously in 3 mice of the same strain, but they failed to grow.
Extensive hypophyseal hyperplasias and adenomas appeared relatively more frequently in male than in female mice, probably because of the greater average survival period in the males. Many female mice died with pyometra after comparatively brief estrogenic treatment. The one female which lived for 415 days and which received 16.6y of estradiol benzoate weekly had been hysterectomized prior to starting the injections. The extreme hypophyseal enlargements appeared in mice which tolerated treatment for from 80 to nearly 200 days longer than the average life of all mice in each series (Table 1) .
Smaller amounts of estradiol benzoate (8.3y weekly) were less toxic; the average survival was from 90 to 120 days longer than in mice receiving twice as much estrogen ( The existence of genetic or at least strain-limited factors in the appearance of mammary tumors5 and testicular interstitial-cell hypertrophy3 in mice treated with estrogens has already been shown. The strain-limited response of the pituitary gland may now also be added to this list.
The strains of mice used in this study were initially selected and inbred for the tendency to develop or fail to develop mammary tumors. The C57 strain in this laboratory has a very low incidence of spontaneous mammary tumors. None of the 106 mice used in the present study developed such tumors. However, the tendency to develop mammary tumors cannot be associated with the absence of the tendency to develop hypophyseal tumors, since in other laboratories high-mammary-tumor strains have developed hypophyseal hyperplasia and adenomas.'0 Likewise, in this laboratory other very low-mammary-tumor strains (N and JK) have not developed tumors of the hypophysis following the injections of comparable amounts of estrogens.
The adrenals of mice of the C57 strain showed extreme "brown degeneration" following the injection of estrogens. Though these changes might be associated with the tendency to develop hypophyseal lesions, they could not be associated with the tendency to develop mammary tumors. The effects of dose within the ranges used indicated, as previously suggested, that the duration of treatment rather than the amount (excluding amounts not satisfactorily tolerated) is of greater significance. Pyometra, urine retention with an associated extreme hydronephrosis, and extensive hemorrhages along the large abdominal or thoracic vessels were the most common causes of death in mice of the C57 strain. These conditions occurred at an earlier age in mice receiving the larger doses of hormone. Summary Hypophyseal adenomas did not appear in over 700 mice of 6 inbred strains (A, C3H, CBA, C12I, JK, and N) following the injection of one of several estrogens for prolonged periods. The glands rarely weighed more than 4 mg.
Fifteen of 106 mice of the C57 strain similarly treated had pituitary glands weighing over 12 mg. The pituitary glands weighing less than 26 mg. showed a generalized hypertrophy of the chromophobe cells and distension of the vascular sinuses. Glands weighing from 47 to 87 mg. consisted largely of adenomas of non-granular chromophobic cells.
Mice of the C57 strain showed extensive brown degeneration of the adrenal which may be related to the hypophyseal changes.
